Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49. Policy Forum Mar 2016 Shedding Privacy Along with our Genetic Material: What Constitutes Adequate Legal Protection against Surreptitious Genetic Testing? Nicolle K. Strand, JD, MBioethics Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work. AMA J Ethics. 2016;18(3):264-271. doi: 10.1001/journalofethics.2016.18.3.pfor2-1603. Medicine and Society Oct 2019 How Should Decision Aids Be Used During Counseling to Help Patients Who Are “Genetically at Risk”? Natalie Evans, PhD, Suzanne Metselaar, PhD, Carla van El, PhD, Nina Hallowell, DPhil, MA, and Guy Widdershoven, PhD Prognostic uncertainty about risk creates demand for ongoing communication and facilitated reflection about goals and values. AMA J Ethics. 2019;21(10):E865-872. doi: 10.1001/amajethics.2019.865. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495. Health Law Jun 2022 النُهج المتمحورة حول الناجين من العنف الجنسي المرتبط بالنزاع في القانون الإنساني الدولي وقانون حقوق الإنسان Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil AMA J Ethics. 2022;E495-517. doi: 10.1001/amajethics.2022.495. Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93. Case and Commentary Feb 2023 How Should Race and Resource Context Influence How Neglect Is Considered by Clinicians? David Kelly, JD, MA and Jerry Milner, DSW Separation of children from their parents is one possible traumatizing consequence of a mandated report, which is not to be taken lightly. AMA J Ethics. 2023;25(2):E100-108. doi: 10.1001/amajethics.2023.100. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last »
State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49.
Policy Forum Mar 2016 Shedding Privacy Along with our Genetic Material: What Constitutes Adequate Legal Protection against Surreptitious Genetic Testing? Nicolle K. Strand, JD, MBioethics Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work. AMA J Ethics. 2016;18(3):264-271. doi: 10.1001/journalofethics.2016.18.3.pfor2-1603.
Medicine and Society Oct 2019 How Should Decision Aids Be Used During Counseling to Help Patients Who Are “Genetically at Risk”? Natalie Evans, PhD, Suzanne Metselaar, PhD, Carla van El, PhD, Nina Hallowell, DPhil, MA, and Guy Widdershoven, PhD Prognostic uncertainty about risk creates demand for ongoing communication and facilitated reflection about goals and values. AMA J Ethics. 2019;21(10):E865-872. doi: 10.1001/amajethics.2019.865.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495.
Health Law Jun 2022 النُهج المتمحورة حول الناجين من العنف الجنسي المرتبط بالنزاع في القانون الإنساني الدولي وقانون حقوق الإنسان Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil AMA J Ethics. 2022;E495-517. doi: 10.1001/amajethics.2022.495.
Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93.
Case and Commentary Feb 2023 How Should Race and Resource Context Influence How Neglect Is Considered by Clinicians? David Kelly, JD, MA and Jerry Milner, DSW Separation of children from their parents is one possible traumatizing consequence of a mandated report, which is not to be taken lightly. AMA J Ethics. 2023;25(2):E100-108. doi: 10.1001/amajethics.2023.100.